Analyst Research

Report Title Price
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Aspen Pharmacare Holdings Ltd Comments On H1 2013 Earnings Guidance


Thursday, 21 Feb 2013 01:00am EST 

Aspen Pharmacare Holdings Ltd announced that for the first half of 2013, it expects diluted normalised headline earnings per share (DNHEPS) from continuing operations, headline earnings per share and earnings per share to exceed those reported in the comparative period, first half of 2012, within the following ranges of headline earnings per share 15%-19% and earnings per share 5%-9%. 

Company Quote

33438.33
538.0 +1.64%
17 Sep 2014